Gustavo Kinrys, MD

Original Research

Baseline Disability and Poor Functioning in Bipolar Disorder Predict Worse Outcomes: Results From the Bipolar CHOICE Study

January 27, 2016

Thilo Deckersbach, Andrew A. Nierenberg, Melvin G. McInnis, et al

Original Research

Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): A Pragmatic 6-Month Trial of Lithium Versus Quetiapine for Bipolar Disorder

January 27, 2016

Andrew A. Nierenberg, Susan L. McElroy, Edward S. Friedman, et al

Original Research

A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Trial of Ziprasidone as Monotherapy for Major Depressive Disorder

December 15, 2012

George I. Papakostas, Ottavio V. Vitolo, Waguih W. IsHak, et al

Original Research

Levetiracetam as Adjunctive Therapy for Refractory Anxiety Disorders

July 16, 2007

Gustavo Kinrys, John J. Worthington, Lisa Wygant, et al

Original Research

An Open-Label Trial of Risperidone Augmentation for Refractory Anxiety Disorders

March 15, 2006

Naomi M. Simon, Elizabeth A. Hoge, Diana Fischmann, et al

Original Research

Levetiracetam for Treatment-Refractory Posttraumatic Stress Disorder.

February 15, 2006

Gustavo Kinrys, Lisa E. Wygant, Tamara B. Pardo, et al

Original Research

Aripiprazole Augmentation of Selective Serotonin Reuptake Inhibitors for Treatment-Resistant Major Depressive Disorder

October 14, 2005

George I. Papakostas, Timothy J. Petersen, Gustavo Kinrys, et al

Original Research

An Open-Label Study of Levetiracetam for the Treatment of Social Anxiety Disorder

September 1, 2004

Naomi M. Simon, John J. Worthington, Alicia C. Doyle, et al

Baseline Disability and Poor Functioning in Bipolar Disorder Predict Worse Outcomes: Results From the Bipolar CHOICE Study

Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): A Pragmatic 6-Month Trial of Lithium Versus Quetiapine for Bipolar Disorder

A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Trial of Ziprasidone as Monotherapy for Major Depressive Disorder

Levetiracetam as Adjunctive Therapy for Refractory Anxiety Disorders

An Open-Label Trial of Risperidone Augmentation for Refractory Anxiety Disorders

Levetiracetam for Treatment-Refractory Posttraumatic Stress Disorder.

Aripiprazole Augmentation of Selective Serotonin Reuptake Inhibitors for Treatment-Resistant Major Depressive Disorder

An Open-Label Study of Levetiracetam for the Treatment of Social Anxiety Disorder

ELSEWHERE:

FOLLOW US:

Gustavo Kinrys, MD

Baseline Disability and Poor Functioning in Bipolar Disorder Predict Worse Outcomes: Results From the Bipolar CHOICE Study

Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): A Pragmatic 6-Month Trial of Lithium Versus Quetiapine for Bipolar Disorder

A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Trial of Ziprasidone as Monotherapy for Major Depressive Disorder

Levetiracetam as Adjunctive Therapy for Refractory Anxiety Disorders

An Open-Label Trial of Risperidone Augmentation for Refractory Anxiety Disorders

Levetiracetam for Treatment-Refractory Posttraumatic Stress Disorder.

Aripiprazole Augmentation of Selective Serotonin Reuptake Inhibitors for Treatment-Resistant Major Depressive Disorder

An Open-Label Study of Levetiracetam for the Treatment of Social Anxiety Disorder

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles